Wes Streeting pushes ahead with NHS puberty blockers clinical trial as high court rules ban lawful
IndependentAUG 2024
The house of cards that is "youth gender medicine" is surely crumbling. As revealed by the Cass Review, there is a shocking dearth of high-quality evidence for puberty blockers, which flies in the face of the repeated assurances made by the media to their efficacy. This court upheld common sense, and keeps untested medicine out of the hands of vulnerable children. The court shut down the zombie lie of this experimental medicine being safe and effective.
The healthcare needs of an incredibly vulnerable population have been made into a political football, and we seem to have forgotten that the lives of real children are being affected. When treating a young patient with gender dysphoria, the course of treatment ought to be determined by the doctors and the family, not by politicos. Puberty blockers can help a small group of patients, and a tool needed to ensure their quality of life cannot be taken away wantonly.